Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion - PubMed (original) (raw)
Comparative Study
. 2011 Apr;42(4):1097-104.
doi: 10.1161/STROKEAHA.110.598359. Epub 2011 Feb 24.
Affiliations
- PMID: 21350203
- DOI: 10.1161/STROKEAHA.110.598359
Comparative Study
Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion
Takuro Miyazaki et al. Stroke. 2011 Apr.
Abstract
Background and purpose: Thrombolysis therapy using tissue-type plasminogen activator (t-PA) is occasionally accompanied by harmful outcomes, including intracerebral hemorrhage. We have reported that Stachybotrys microspora triprenyl phenol-7 (SMTP-7), a candidate thrombolytic drug, has excellent therapeutic effect on cerebral infarction in embolic stroke model in mice; however, little is known regarding whether this agent influences cerebrovascular inflammation following thrombolytic reperfusion. The current study aimed to compare the effects of recombinant t-PA (rt-PA) and SMTP-7 on cerebrovascular inflammation.
Methods: The impact of rt-PA- and SMTP-7-induced thrombolytic reperfusion on leukocyte dynamics was investigated in a photochemically induced thrombotic middle cerebral artery occlusion (tMCAo) model in mice.
Results: Both rt-PA and SMTP-7 administration in tMCAo mice (each 10 mg/kg) resulted in thrombolytic reperfusion. The SMTP-7-administered mice showed relatively mild rolling and attachment of leukocytes to the vascular wall in the middle cerebral vein, with weak peroxynitrite reactions and proinflammatory gene expression (IL-1β, TNF-α, ICAM-1, and VCAM-1); thus, a small infarct volume compared with rt-PA-administered mice. In vitro study suggested that rt-PA at 20 μg/mL, but not SMTP-7 at a similar concentration, promotes cytokine-induced reactive oxygen species generation in cultured endothelial cells; moreover, SMTP-7 suppressed cytokine-induced VCAM-1 induction in the cells and leukocyte/ endothelial cell adhesions.
Conclusions: Relatively mild cerebrovascular inflammation and cerebral infarction in the SMTP-7 mice, compared with in rt-PA mice, is thought to be caused at least in part by direct antioxidative actions of SMTP-7 in ECs.
Similar articles
- Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke.
Hasumi K, Suzuki E. Hasumi K, et al. Int J Mol Sci. 2021 Jan 19;22(2):954. doi: 10.3390/ijms22020954. Int J Mol Sci. 2021. PMID: 33477998 Free PMC article. Review. - Reduction of Ischemia Reperfusion-Related Brain Hemorrhage by Stachybotrys Microspora Triprenyl Phenol-7 in Mice With Antioxidant Effects.
Huang Y, Ohta Y, Shang J, Li X, Liu X, Shi X, Feng T, Yamashita T, Sato K, Takemoto M, Hishikawa N, Suzuki E, Hasumi K, Abe K. Huang Y, et al. J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3521-3528. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.018. Epub 2018 Sep 7. J Stroke Cerebrovasc Dis. 2018. PMID: 30201460 - SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.
Ito A, Niizuma K, Shimizu H, Fujimura M, Hasumi K, Tominaga T. Ito A, et al. Brain Res. 2014 Aug 26;1578:38-48. doi: 10.1016/j.brainres.2014.07.004. Epub 2014 Jul 9. Brain Res. 2014. PMID: 25016287 - A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice.
Shibata K, Hashimoto T, Nobe K, Hasumi K, Honda K. Shibata K, et al. Naunyn Schmiedebergs Arch Pharmacol. 2010 Sep;382(3):245-53. doi: 10.1007/s00210-010-0542-5. Epub 2010 Aug 3. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20680247 Free PMC article. - New developments in thrombolytic therapy.
Collen D, Gold HK. Collen D, et al. Adv Exp Med Biol. 1990;281:333-54. Adv Exp Med Biol. 1990. PMID: 2129372 Review.
Cited by
- FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in _EGFR_-Mutant NSCLC Cells.
Feng J, Li S, Zhang B, Duan N, Zhou R, Yan S, Elango J, Liu N, Wu W. Feng J, et al. Mar Drugs. 2022 Jan 17;20(1):76. doi: 10.3390/md20010076. Mar Drugs. 2022. PMID: 35049931 Free PMC article. - Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability.
Jin Q, Cai Y, Li S, Liu H, Zhou X, Lu C, Gao X, Qian J, Zhang J, Ju S, Li C. Jin Q, et al. Theranostics. 2017 Feb 8;7(4):884-898. doi: 10.7150/thno.18219. eCollection 2017. Theranostics. 2017. PMID: 28382161 Free PMC article. - Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke.
Hasumi K, Suzuki E. Hasumi K, et al. Int J Mol Sci. 2021 Jan 19;22(2):954. doi: 10.3390/ijms22020954. Int J Mol Sci. 2021. PMID: 33477998 Free PMC article. Review. - Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke.
De Silva TM, Brait VH, Drummond GR, Sobey CG, Miller AA. De Silva TM, et al. PLoS One. 2011;6(12):e28393. doi: 10.1371/journal.pone.0028393. Epub 2011 Dec 2. PLoS One. 2011. PMID: 22164282 Free PMC article. - Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice.
Lenglet S, Montecucco F, Denes A, Coutts G, Pinteaux E, Mach F, Schaller K, Gasche Y, Copin JC. Lenglet S, et al. J Cereb Blood Flow Metab. 2014 May;34(5):802-12. doi: 10.1038/jcbfm.2014.9. Epub 2014 Jan 29. J Cereb Blood Flow Metab. 2014. PMID: 24473480 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous